Sustainability > Our Commitment
The PANACELL BIOTECH Research Center has the separation capabilities of
high -purity ADSC, NK Cell, Exosome, and Brown FAT,
which runs through the entire process of cell therapy, as well as the technologies
that track various differentiation of stem cells.
After MNC extraction NK cells of Negative Selection are used for a lot of culture.
Ensure that world -class fat stem cells differentiate into cross -differentiated
technology for brown fat stem cells.
Control the natural killing mechanism at the level of the feelings and antibody particles.
High-efficiency SVF extraction method, stem cell optimization medium research, Brown Fat local, etc.
Ensure the suitable temperature of the cell frozen and thaw, and the stability of the cell bank frozen.
EGF, FGF, Exosome, and other substances such as high-purity extraction and combination technology with other effective substances.
Panacell Biotech Co.Ltd is a global biological enterprise leading the world's
cutting-edge recycled medical and cutting-edge biomedical fields. And Research
institute (Through research on stem cell culture and cell banking, focusing on the
development of various cancers, incurable diseases, and the treatment agents and
technologies of incurable diseases.) Contribute to the development of life and
national competition in related fields.
On April 1, 2022, PANACELL BIOTECH was approved by the Korean Food and
Medical Safety Department to permit a cell treatment facility. At present, 22
biotechnology companies, including university hospitals such as Seoul University
Hospital, Yonsei Medical College, and Panacell Biotech, have been permitted by
the government and are operating cell treatment facilities.
PANACELL BIOTECH focuses on experiments and R & D research development,
inviting global experts in life engineering to provide customers with the best
regenerative medical services.
Technology transfer agreement
- Libya
Clinical trial MOA and GAZI Medical College
- Türkiye
Establishment agreement of cell therapy center
and Yasam Medical Group
PANACELL BIOTECH is the world's leading global biotechnology company
in the field of regeneration medicine and biomedical.
Inhibit prostate hyperplasia
Anti-fibrosis effect
Skin regeneration
Corneal healing: alkaline injury model
Parkinson model rotation test
Behavior Analysis
Before Stem Cell Therapy
After Stem Cell Therapy
Use the patient's own cells to repair damaged brain cells through stem cells to ensure stability
Self -proliferation can be divided into all tissue cells in the living body
The ability to go to the damaged parts that need to be repaired (Homing effect)
Replace or regenerate damage organization
Animal model (successful transplantation)
Overseas clinical trials and development of medical products for patients with obesity and diabetes
Human brown fat collection technology
Brown fat SVF collection technology
Brown fat from white fat
Brown fat ADSC mass production
Stem cell purity was 99.3%
▶
Immune cell· Because it is not a cell, it has no chance of cancer.
· Since it can be used after disinfection, there is no risk of bacterial infection.
· Due to the small volume, they can spread to all parts of the body, including the brain.
· Since it does not cause immune response, it can be commonly used by everyone.
· It is non -toxic because there is no artificial compound.
· Mass production difficulty
· The duration is short and the injection needs to be repeated
Research on the high purity and high -efficiency fat stem cell culture medium
Compared with the products of other companies, the virus marker
(TSG101) of our company's exocrine body shows more than 100 times
Project | Indicator | Leads/Candies | Preclinical | Phase 1 | Phase 2 | Phase 3 |
---|---|---|---|---|---|---|
Stem cells | Macular degeneration | |||||
Parkinson's Disease | ||||||
Hair follicle stem cell collector | ||||||
PN-NK | Relapsed acute myeloid leukemia | |||||
Car-NK | Combination therapy of radiation and anticancer agents | |||||
Exosomes | Cosmetics | Done |
||||
Hair follicle stem cell collector |
PANACELL Biotechnology Cell Bank Project | ||
---|---|---|
stem cell | stock capacity | PERIOD |
ADSC | 10 million cells | 5years(long-term 20years) |